Interleukin (IL)-10 and B-cell activating factor (BAFF) can further increase the expression of CD72 in CD19+CD27+ B cells [45], with the detection of obviously lower CD72 mRNA expression in patients with active ITP than that in those in remission. This evidence concerns the gene CD72 and autoimmune thrombocytopenic purpura.